A major U.S. cannabis operator has expanded its Florida presence with a new medical marijuana dispensary designed to serve patients in a region that has historically lacked convenient access points.

iAnthus Capital Holdings opened its 26th Florida location in Tequesta-Jupiter on April 14, according to a company announcement. The dispensary operates under the GrowHealthy brand and is strategically positioned along the US-1 corridor to serve northern Palm Beach County, including Tequesta and surrounding communities.

The opening represents a measured expansion in one of the nation's most competitive medical cannabis markets. Florida's medical marijuana program, established through a 2016 constitutional amendment, has grown to serve over 800,000 registered patients across the state, creating intense competition among licensed operators for market share.

Targeting Geographic Gaps

Kelly Heinichen, Vice President of Retail Operations for iAnthus, emphasized the location's strategic value in addressing service gaps. "Our GrowHealthy dispensary in Tequesta-Jupiter expands access for patients across a region that has had limited nearby options," Heinichen said in a statement.

The company is positioning the location as a convenience play focused on operational efficiency. "We're focused on a seamless experience for the patients of Palm Beach County: fast service, knowledgeable teams, and best-in-class flower genetics," Heinichen added.

The dispensary offers a full product range including flower, vaporizers, concentrates, and edibles. Products are sold under iAnthus' house brands: The Vault, Sunshine State, and MPX—each targeting different price points and consumer preferences within Florida's medical framework.

Florida's Consolidating Market

The expansion comes as Florida's cannabis landscape continues to consolidate around a small number of vertically integrated operators. The state's regulatory structure requires companies to handle cultivation, processing, and retail under a single license—a model that favors well-capitalized players capable of managing complex supply chains.

iAnthus, which operates cannabis businesses across multiple U.S. states, announced plans for the Tequesta-Jupiter location in February. The company's Florida footprint now includes 26 dispensaries, though it remains smaller than dominant in-state operators like Trulieve, which operates over 100 locations statewide.

The northern Palm Beach County market represents both opportunity and challenge. While the region includes affluent communities with aging populations—demographics that often correlate with medical cannabis use—it also faces saturation pressures as operators compete for patient loyalty in a market where switching costs are low.

Florida's medical cannabis sales reached approximately $2 billion in 2025, according to industry estimates, making it one of the largest medical-only markets in the United States. However, the state has not yet legalized recreational use, despite multiple ballot initiatives and legislative proposals in recent years.

Retail Model and Patient Acquisition

iAnthus describes its retail approach as focused on "efficiency, education, and repeat engagement"—industry shorthand for streamlined purchasing processes, staff training on product selection, and loyalty programs designed to encourage return visits.

The company's emphasis on "best-in-class flower genetics" reflects broader industry trends toward product differentiation based on cultivation quality. As price competition intensifies, operators are increasingly marketing proprietary strains and cultivation techniques as competitive advantages.

The Tequesta-Jupiter location's position along US-1, a major north-south artery, is designed to maximize visibility and accessibility for patients traveling from communities throughout northern Palm Beach County. Geographic convenience remains a key factor in dispensary selection, particularly for patients managing chronic conditions who require regular product access.

iAnthus trades on the Canadian Securities Exchange and over-the-counter markets in the United States. Like most U.S. cannabis operators, the company faces significant financial constraints due to federal prohibition, which limits access to traditional banking services and prevents listings on major U.S. stock exchanges.

The opening adds another data point to Florida's evolving cannabis geography—a patchwork of dispensary clusters in urban centers and strategic placements in underserved suburban and exurban areas where patient density justifies investment but competition remains manageable.